[1]
E. Henrique Vieira Braz et al., “SAFETY AND MORTALITY REDUCTION IN THE USE OF BETA-BLOCKERS IN ACUTE MYOCARDIAL INFARCTION”, EASN, vol. 4, pp. 223–226, Jun. 2022, doi: 10.51249/easn04.2022.788.